Bristol-Myers Squibb jumps on Opdivo cancer drug test
January 12, 2015 at 08:17 AM EST
Bristol-Myers Squibb Co. says a late-stage study of its advanced skin-cancer drug Opdivo met its primary endpoint and the company would end the trial early.
